1. Home
  2. MNMD vs IIIV Comparison

MNMD vs IIIV Comparison

Compare MNMD & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • IIIV
  • Stock Information
  • Founded
  • MNMD 2019
  • IIIV 2012
  • Country
  • MNMD United States
  • IIIV United States
  • Employees
  • MNMD N/A
  • IIIV N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • IIIV EDP Services
  • Sector
  • MNMD Health Care
  • IIIV Technology
  • Exchange
  • MNMD Nasdaq
  • IIIV Nasdaq
  • Market Cap
  • MNMD 672.1M
  • IIIV 570.8M
  • IPO Year
  • MNMD N/A
  • IIIV 2018
  • Fundamental
  • Price
  • MNMD $8.24
  • IIIV $29.24
  • Analyst Decision
  • MNMD Strong Buy
  • IIIV Buy
  • Analyst Count
  • MNMD 10
  • IIIV 7
  • Target Price
  • MNMD $28.11
  • IIIV $28.57
  • AVG Volume (30 Days)
  • MNMD 2.1M
  • IIIV 257.2K
  • Earning Date
  • MNMD 02-26-2025
  • IIIV 02-06-2025
  • Dividend Yield
  • MNMD N/A
  • IIIV N/A
  • EPS Growth
  • MNMD N/A
  • IIIV 21740.15
  • EPS
  • MNMD N/A
  • IIIV 4.87
  • Revenue
  • MNMD N/A
  • IIIV $236,560,000.00
  • Revenue This Year
  • MNMD N/A
  • IIIV $11.47
  • Revenue Next Year
  • MNMD N/A
  • IIIV $8.50
  • P/E Ratio
  • MNMD N/A
  • IIIV $8.39
  • Revenue Growth
  • MNMD N/A
  • IIIV 20.85
  • 52 Week Low
  • MNMD $4.35
  • IIIV $18.52
  • 52 Week High
  • MNMD $12.22
  • IIIV $29.80
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 56.38
  • IIIV 78.80
  • Support Level
  • MNMD $7.86
  • IIIV $25.22
  • Resistance Level
  • MNMD $10.20
  • IIIV $26.03
  • Average True Range (ATR)
  • MNMD 0.73
  • IIIV 0.85
  • MACD
  • MNMD 0.13
  • IIIV 0.26
  • Stochastic Oscillator
  • MNMD 47.18
  • IIIV 95.08

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

About IIIV i3 Verticals Inc.

i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.

Share on Social Networks: